Kusuri No Aoki Holdings (3549) Fundamentals 2026 — P/E 21.6x, Revenue Analysis | SniperIQ
Kusuri No Aoki Holdings (3549) is a JP-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ¥362.9B, trading at ¥3822.00 on the JPX. This SniperIQ fundamentals page covers Kusuri No Aoki Holdings's valuation (P/E 21.6x, P/B 2.5x), profitability (net margin 3.0%), revenue (¥566.9B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Kusuri No Aoki Holdings's market cap?
Kusuri No Aoki Holdings (3549) has a market capitalization of approximately ¥362.9B, trading at ¥3822.00 on the JPX. Market cap moves with the live share price.
What is Kusuri No Aoki Holdings's P/E ratio?
Kusuri No Aoki Holdings's trailing twelve-month P/E ratio is 21.6x, with a price-to-book (P/B) of 2.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Kusuri No Aoki Holdings?
Kusuri No Aoki Holdings runs a net profit margin of 3.0%, a gross margin of 23.8%, and an operating margin of 4.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Kusuri No Aoki Holdings generate?
Kusuri No Aoki Holdings reported revenue of ¥566.9B for fiscal year 2025, with net income of ¥17.1B and earnings per share (EPS) of 176.94. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Kusuri No Aoki Holdings pay a dividend?
Kusuri No Aoki Holdings offers a trailing dividend yield of about 1.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Kusuri No Aoki Holdings financially healthy?
Kusuri No Aoki Holdings carries a debt-to-equity ratio of 1.06x and a current ratio of 1.32x, with a market beta of 0.01. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Kusuri No Aoki Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Kusuri No Aoki Holdings (3549) the key facts are: market cap ¥362.9B, P/E 21.6x, revenue ¥566.9B, 52-week range 3351-4815. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Kusuri No Aoki Holdings's full fundamentals live
Get Kusuri No Aoki Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.